baber/WOPTO huggingface dataset:
Patent NZ-571667-A (NZ)
Title: Valve with a fluid outlet, a rotatable crank pin, a shut-off valve, a crank pin, and a metering valve
Inventor: PICTON DAVID JOHN
IPC: F16K11/16
Filed: 2008-09-30
Abstract: A valve having a fluid inlet, a fluid outlet, a rotatable crank pin, a shut-off valve member, and a metering valve member is disclosed. The shut-off valve is operatively-connected to the crank pin, and the metering valve operatively-connected to the crank pin. The metering valve has a small bypass passageway, which enables a very small flow of water to bypass the metering valve member when the metering valve member is in its fully closed position. Rotation of the crank pin causes the metering valve member or the shut-off valve member to move into a selected position.
Patent NZ-572087-A (NZ)
Title: A buried tank with a double skin and a spill receptacle surrounding the opening to capture spilled liquid
Inventor: HUANG XIAODONG
IPC: B65D90/501
Filed: 2007-05-11
Abstract: A buried environmental-protection safety oil tank is disclosed. The double walled tank is able avoid pollution to the environment by containing any spills and preventing explosions. The tank has a shell (1) formed as a double walled structure including inner (11) and outer (12) walls between which a hollow (13) is formed. A blocking and explosion-proof material (3) fills the tank and the hollow helping to prevent any explosions initiating by an unintended spark. An oil leak monitoring device (2) is installed in the hollow above a spill pool (4) which is set around the manhole cover (14) of the tank shell (1). Any spills during filling are channelled by the hollow (13) to the bottom of the tank, which can be drawn off through the oil drain valve (9).
Patent NZ-572724-A (NZ)
Title: A fluid dispenser
Inventor: LINTERN RICHARD DAVID
IPC: B05B1/34
Filed: 2007-05-30
Abstract: A fluid dispenser is disclosed. The fluid dispenser has a fluid outlet through which fluid will, in use, be dispensed, a seal for sealing the fluid outlet which is movable from a normal closed state in which the seal prevents fluid being dispensed through the fluid outlet to an open state in which the seal opens the fluid outlet for dispensing therefrom, a member movable between a normal first position, in which the member acts on the seal to locate the seal in the closed state, and a second position, which enables the seal to move to the open state, and a biasing mechanism which biases the member to its first position. The dispenser is adapted such that the member moves from the first position to the second position in response to actuation of the fluid dispenser. The seal is supported on a support member having a passageway therethrough, where the member moves between the first and second positions relative to the support member and the seal. The member has a free end which, in the first position, extends into the passageway to push against the seal to push the seal into sealing engagement with the fluid outlet, and wherein the member and the support member are interengageable to limit how far the free end is able to extend into the passageway to push against the seal.
Patent NZ-574004-A (NZ)
Title: Sexual stimulation device with vibrator unit comprising a switch with actuating means pushable in one direction
Inventor: TASKER SEAN JOSEPH
IPC: A61F5/37
Filed: 2007-07-05
Abstract: A vibrator unit for a sexual stimulation device is disclosed. The vibrator unit comprises a housing (41, 42) in which is disposed an electric motor (43) provided with a rotatably driveable eccentric mass (55). The operation of the electric motor (43) produces vibrations. A battery (44) is disposed in the housing (41, 42) for providing power to the electric motor (43). There is an electric conductor (50) that connects a pole of the battery (44) to a first electrode of the electric motor (43) and a switch (54) situated in a cavity defined between the electric motor (43) and the battery (44). The electric conductor (50) connects the other pole of the battery to a second electrode of the electric motor (43). The switch (54) comprises a bi stable actuating means (47) which is pushed in the same direction to switch on or switch off the electric motor (43). The housing (41, 42) of the unit comprises a resiliently depressible sealing element (3) that surmounts the actuating means (47).
Patent NZ-576750-A (NZ)
Title: Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
Inventor: JIMENEZ JUAN-MIGUEL
IPC: C07D403/12
Filed: 2007-11-01
Abstract: Disclosed is a compound of formula (I) wherein the substituents are as disclosed in the description. Examples of compounds of formula (I) includes: 6-(Azetidin-3-yl)-2-(2-chlorophenyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine and 6-(Azetidin-1-yl)-2-(2-chlorophenyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine. Also disclosed is a composition comprising a compound of formula(I), the use of a compound of formula (I) for making a medicament and the method of inhibiting GSK-3 activity in an ex vivo or in vitro sample.
Patent NZ-579704-A (NZ)
Title: A method in a milking system for creating a required vacuum level and computer program products
Inventor: IDENSJO HENRIK
IPC: G05D16/20
Filed: 2008-04-02
Abstract: The disclosure relates to a method in a milking system for creating a required vacuum level, the milking system comprising at least two variable speed vacuum pumps P1, P2. The method comprises the steps of: utilizing a first variable speed vacuum pump P1 for creating the required vacuum level within the milking system; monitoring the vacuum level requirement within the milking system, and when the vacuum level requirement of the milking system is such that the speed of the first variable speed vacuum pump P1 reaches a first speed threshold then: starting a second variable speed vacuum pump P2, and running the first and second variable speed vacuum pumps P1, P2 in parallel for creating the required vacuum level. The disclosure also relates to computer program products.
Patent NZ-584721-A (NZ)
Title: AMIDE LINKED MODULATORS OF gamma-SECRETASE
Inventor: HO CHIH YUNG
IPC: A61P25/28
Filed: 2008-10-14
Abstract: A compound of Formula (I) where A and R1-R8 are as defined in the claims. The compounds of Formula (I) can be used for the treatment of diseases associated with gamma-secretase activity, in particular the disease can be Alzheimer's disease, cerebral amyloid angiopathy, multi-infarct dementia, dementia pugilistica or Down syndrome.
Patent NZ-586403-A (NZ)
Title: A method of cooling a neck ring in a glassware forming machine
Inventor: FLYNN ROBIN L
IPC: C03B9/38
Filed: 2005-07-14
Abstract: A method of cooling a neck ring carried by a neck ring arm (14) in a glassware forming machine is disclosed. The machine includes a section box (20) providing a supply of cooling air, and a plunger cylinder (76) having an axis. The method includes the steps of: a) providing an air plenum (48) having an internal cavity defining a flow path that extends radially toward the axis and axially to an outlet, b) providing an air passage (115) adjacent to the neck ring (16), the air passage (115) being aligned with the outlet (90) of the air plenum (48), and c) directing cooling air from the section box (20) to the air passage (115) so the cooling air flows radially in the air plenum (48) toward the axis and axially to the outlet (90). The cooling air is then directed axially from the outlet (90) through an array of axially oriented openings (98) in a plunger wear plate (92) to the air passages (115) to cool the neck ring (16). The air passages (115) are defined at least in part in the neck ring arm (14) so that the step of directing cooling air also provides cooling air to at least a portion of the neck ring arm (14), when the neck ring arm (14) overlies the plunger wear plate.
Patent NZ-589262-A (NZ)
Title: Antisense formulation
Inventor: HAYES THOMAS K
IPC: A61K31/713
Filed: 2009-07-13
Abstract: Provided is a room temperature stable and minimal aggregate liquid formulation comprising (a) a specified oligonucleotide or a variant oligonucleotide with no more than 3 varied bases, with the proviso that any variant bases are non-sequential; and (b) an aqueous carrier comprising a aggregation-preventing compound selected from the group consisting of mono and disaccharides and/or sugar alcohols, wherein said formulation is stable for at least 6 hours with no detectable formulation of aggregation as measured by HPLC. Further provided are variants with methylated nucleotides at specific locations.
Patent NZ-589526-A (NZ)
Title: Method for led-module assembly with light and vacuum seal testing and machine readable marking for central database information recording
Inventor: GUILLIEN WAYNE
IPC: F21S4/00
Filed: 2009-05-27
Abstract: 589526 Disclosed is a method of LED-module assembly to allow heat dispersion and protection to the electronic components used. The method comprises the steps of providing a base portion with a base inner surface and a cover with a cover inner surface, the base inner surface and the cover inner surface together defining a module interior, the cover having at least one opening. The cover is placed with its inner surface facing up providing LED lens gravity retention within the cover inner surface. A sealing member is put over the cover inner surface. A LED lens is positioned into the cover opening, a LED emitter is aligned over the LED lens, and the module interior is sealed by installing the base portion over the cover, followed by vacuum testing the sealing for water/air-tightness of the LED module interior. The LED emitter is powered and the LED module is imaged to test light-output characteristics.
Patent NZ-590410-A (NZ)
Title: A method for preparing a liquid nisin composition for food preservation
Inventor: VISSER JOHANNES MARTINUS JACOBUS
IPC: A01N63/50
Filed: 2009-08-12
Abstract: 590410 Disclosed is a method for preparing a liquid nisin composition, comprising the steps of: (a) mixing powder nisin with an aqueous solution to prepare a first liquid nisin containing composition having a pH of 3.5 to 12 and a final inorganic salt concentration of 1.5 M or below; (b) isolating solid compounds from the prepared first liquid nisin containing composition by centrifugation, filtration or any combination thereof; (c) contacting the isolated solid compounds with a solution having a pH of 1 to 3 to prepare a second liquid nisin composition; and optionally (d) removing solid compounds from the second liquid nisin composition and / or e) adjusting the pH of the second liquid nisin composition to a pH between 2 and 6. Also disclosed is the use of a liquid nisin composition as prepared above for use as a preservative for food, feed or agricultural products. A method for producing a solid nisin composition comprising the step of subjecting a liquid composition as prepared above, to a drying step, Iyophilisation step, crystallisation step or precipitation step.
Patent NZ-596041-A (NZ)
Title: Use of guanethidine for treating hypertension by local vascular delivery
Inventor: SEWARD KIRK PATRICK
IPC: A61K31/155
Filed: 2010-04-22
Abstract: NZ 596041 Disclosed is the use of guanethidine in the manufacture of a medicament for treating hypertension in a human patient by lowering systemic blood pressure in the human patient, wherein the guanethidine is to be administered into a tissue surrounding a renal blood vessel and surrounding renal nerves by injection into the tissue.
Patent NZ-596474-A (NZ)
Title: Ultraviolet protective fabrics based on man-made cellulosic fibres
Inventor: BISJAK CLEMENS
IPC: D01F1/10
Filed: 2010-05-03
Abstract: 596474 Disclosed herein are UV protective fabrics, whereupon these fabrics are made of UV protective cellulosic fibres, namely manufactured by the Modal or the Lyocell process. Besides the permanent and inherent protection against UV rays of the named fibre materials and thus fabrics, UV protection is still guaranteed, when the fabrics are wet and stretched. As a result of fibre swelling, the fabric construction becomes denser and as a direct result, UV transmission is significantly reduced compared to the dry and stretched state. In a preferred embodiment the UV-protective fabric, contains high-tenacity man-made cellulosic fibres which contain between 0.1 and 1.5% (w/w) of an incorporated nano-scale TiO2 pigment with a particle distribution characterized by an x50 lower than 1000 nm and x99 lower than 2000 nm, wherein the high-tenacity manmade cellulosic fibres are man-made cellulosic fibres with a tenacity at break of at least 30 cN/tex in the conditioned state and at least 18 cN/tex in the wet state, both parameters evaluated according to BISFA and the fabric has a mass per unit area of 120 to 270 g/m2.
Patent NZ-596699-A (NZ)
Title: Inner housing for a drug delivery device
Inventor: PLUMPTRE DAVID
IPC: A61M5/315
Filed: 2010-05-28
Abstract: 596699 A dose setting mechanism (200) for a drug delivery device comprises an outer housing (204), an inner housing (208), a driver (209), a dial sleeve (206) disposed between the outer housing and the inner housing, and a dose dial grip (202) rotatably coupled to the dial sleeve. The inner side of the dial sleeve is rotatably engaged with an external groove (see 232, figure 10) of the inner housing, which is advantageous in allowing greater outer surface area for a scale arrangement (see 242, figures 12 & 13) and also makes it more difficult for dirt from outside the mechanism to become logged in the groove. The dial grip is non-rotatably coupled to a dose button (216). To set a dose, the dose dial grip is rotated with respect to both the outer housing and the inner housing, such that the dial sleeve is translated away from both the outer housing and the inner housing. The inner housing is operatively coupled to the driver and guides the driver to dispense a dose set by the dose setting mechanism.
Patent NZ-601830-A (NZ)
Title: Inhaler drawing air through capsule after capsule cut by blades
Inventor: VILLAX PETER
IPC: A61M15/00
Filed: 2011-04-18
Abstract: 601830 A dry powder inhaler for pulmonary or nasal use, employing capsules containing a dose of powder for inhalation, comprising two operating components and an optional cover. Air is drawn by the patient via a mouthpiece or nosepiece (303) which is in communication with the capsule and travels via air paths through the device and through the capsule thereby dispersing and entraining the dose of powder. The capsule is cut by cutting means (350, 351) located on one of the components, in a manner which eliminates or minimizes capsule debris and minimizes powder leakage during use. The inhaler body (300) and capsule cutting blades comprise a single operating component and they may be manufactured in a single unitary step.
Patent NZ-606723-A (NZ)
Title: Glatiramer acetate molecular weight markers
Inventor: SRINIVASAN SANTHANAKRISHNAN
IPC: G01N33/68
Filed: 2011-07-28
Abstract: Discloses polypeptides having no predetermined amino acid sequence when used as molecular weight markers of glatiramer acetate, wherein said polypeptides have an amino acid composition corresponding to glatiramer acetate and a peak average molecular weight between about 2,000 Daltons and about 40,000 Daltons.
Patent NZ-613913-A (NZ)
Title: Cetp fragments
Inventor: BRUNNER SYLVIA
IPC: C07K16/18
Filed: 2012-06-11
Abstract: Discloses a composition including an isolated peptide consisting of 6 to 20 amino acid residues, the peptide being coupled or fused to a pharmaceutically acceptable carrier, wherein the peptide is derived from amino acid sequence VFKGTLKYGYTTAWWLGIDQSIDFEIDSAI, and comprises the amino acid sequence WWLGID.
Patent NZ-622585-A (NZ)
Title: Conditionally replicating adenovirus
Inventor: MIZUGUCHI HIROYUKI
IPC: C12Q1/04
Filed: 2012-02-17
Abstract: Disclosed is a recombinant adenovirus, which comprises: -a replication cassette comprising a polynucleotide which comprises human telomerase reverse transcriptase promoter, E1A gene, IRES sequence and E1B gene in this order and which comprises a target sequence of a first microRNA, wherein the replication cassette is integrated into the E1 region of the adenovirus genome and wherein the first microRNA is expressed in non-cancer cells; and -a labelling cassette comprising a reporter gene and a promoter capable of regulating the expression of the gene, wherein the labelling cassette is integrated into the E3 region of the adenovirus genome.
Patent NZ-624036-A (NZ)
Title: Method and system to facilitate an in-person exchange
Inventor: OSMAN LAWRENCE A
IPC: G06Q30/06
Filed: 2012-10-05
Abstract: Certificates can be redeemed for a physical product during an in-person exchange. This can be based upon providing to a third party, via an electronic data network, an opportunity to select a physical product to provide to a particular recipient via an in-person exchange; receiving from the third party, via an electronic data network, a selection of the physical product to provide to the particular recipient in an in-person exchange; and providing a message to the particular recipient. The message can comprise, at least in part, a certificate that can be redeemed by the particular recipient for the physical product at a retailer and can further comprise transaction-specific validation information that, when utilized by the retailer, will validate a bearer as being authorized to receive the physical product via the in-person exchange without further additional payment from the bearer to the retailer.
Patent NZ-624139-A (NZ)
Title: Aerosol generating system with consumption monitoring and feedback
Inventor: FLORACK DIONISIUS
IPC: A24F40/65
Filed: 2012-12-28
Abstract: An aerosol-generating system and method of use comprises, a heater element (20) configured to heat a substrate to generate an aerosol, a power source (40) connected to the heater element, a controller (30) connected to the heater element and to the power source configured to control operation of the heater element. The controller includes; a means to detect a change in air flow past the heater element, first data storage means (56) for recording detected changes in airflow past the heater element and data relating to the operation of the heater element, second data storage means comprising a database (57) relating changes in airflow and data relating to the operation of the heater element to the properties of the aerosol and an indication means (59) coupled to the second data storage means for indicating to the user a property of the aerosol delivered to the user.
Patent NZ-625360-A (NZ)
Title: Insulin receptor binding antibodies
Inventor: BHASKAR VINAY
IPC: C07K16/28
Filed: 2010-09-25
Abstract: Disclosed is an allosteric agonist antibody that binds to insulin receptor with an affinity of 10-5,10-6, 10-7, 10-8, 10-9, 10-10, 10-11 M or less and (a) exhibits maximal agonist activity in the absence of insulin that is 20%-80% that of insulin’s maximal agonist activity when measured in pAKT assay, (b) when present with insulin does not alter the EC50 of insulin for INSR by more than 2-fold, and (c) when present with insulin does not alter the KD of insulin for INSR by more than 2-fold.
Patent NZ-700567-A (NZ)
Title: Pesticide composition delivery vehicles
Inventor: HOWARD PHILLIP J
IPC: C08H1/00
Filed: 2013-04-25
Abstract: Vehicles for delivery and release of pesticide compositions are provided. In one aspect, the delivery vehicle is a capsule configured to resist release of a pesticide composition before application of the capsule at a locus where pest control is desired. The capsule is further configured to degrade following application at the locus where pest control is desired to facilitate release of the pesticide composition. In one particular form, a capsule is provided, comprising a shell wall encapsulating a pesticide composition, the shell wall including a gelatin material having a Bloom strength in the range of 270 to 300 grams and a plasticizer composition including a mixture of sorbitol, mannitol and sorbitol anhydrides, wherein the pesticide composition includes a 1,3-dichloropropene and a fumed silica material aftertreated with dimethyldichlorosilane (i.e. Aerosil® R972).
Patent NZ-707308-A (NZ)
Title: Malononitrile compounds for controlling animal pests
Inventor: PAULINI RALPH
IPC: A01P7/00
Filed: 2013-10-22
Abstract: The invention relates to the use of a compound of formula (I) or a salt thereof for combating animal pests, where the symbols and indices are defined in the specification.
Patent NZ-721534-A (NZ)
Title: Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine
Inventor: CHEN JUNLI
IPC: C07D417/14
Filed: 2015-01-21
Abstract: The present invention relates to a novel process for the preparation of a compound of the formula (I) and pharmaceutically acceptable acid addition salts thereof, which is useful for prophylaxis and treatment of respiratory syncytial virus (RSV) infection in mammal or human being.
Patent NZ-722077-A (NZ)
Title: Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
Inventor: MEKONNEN BELEW
IPC: C07D487/04
Filed: 2014-12-19
Abstract: This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those benzodiazepine derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with central nervous system (CNS) disorders. In particular, it relates to the use of a a5- containing GABAA receptor agonist (e.g., a α5 -containing GABAA receptor positive allosteric modulator) as described herein in treating cognitive impairment associated with central nervous system (CNS) disorders in a subject in need or at risk thereof, including, without limitation, subjects having or at risk for age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI (aMCI), Age-Associated Memory Impairment (AAMI), Age Related Cognitive Decline (ARCD), dementia, Alzheimer’s Disease(AD), prodromal AD, post traumatic stress disorder (PTSD), schizophrenia, bipolar disorder, amyotrophic lateral sclerosis (ALS), cancer-therapy-related cognitive impairment, mental retardation, Parkinson’s disease (PD), autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction.
Patent NZ-738658-A (NZ)
Title: Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them
Inventor: PARK SU JIN
IPC: C12P13/10
Filed: 2016-07-19
Abstract: The invention concerns a modified microorganism of the genus Corynebacterium producing putrescine or ornithine, wherein activities of N-acetylglutamate synthase from E. coli and acetylornithine deacetylase from E. coli are introduced to the genus Corynebacterium having an activity of acetylglutamate synthase or ornithine acetyltransferase (ArgJ). The invention concerns the introduction of N-acetylglutamate synthase and acetylornithine deacetylase from E. coli to Corynebacterium with bifunctional ornithine acetyltransferase/N-acetylglutamate synthase activity so as to improve the ornithine or putrescine production of Corynebacterium.